Brokerages Set Pediatrix Medical Group, Inc. (NYSE:MD) Price Target at $10.30

Pediatrix Medical Group, Inc. (NYSE:MD) has been assigned a consensus recommendation of “Hold” from the four ratings firms that are currently covering the firm, Marketbeat reports. Four analysts have rated the stock with a hold rating. The average 1 year price target among brokers that have issued a report on the stock in the last year is $10.30.

MD has been the topic of a number of analyst reports. Jefferies Financial Group cut their price objective on shares of Pediatrix Medical Group from $10.00 to $9.00 and set a “hold” rating on the stock in a research report on Wednesday, March 6th. Truist Financial reduced their price objective on shares of Pediatrix Medical Group from $10.50 to $10.00 and set a “hold” rating on the stock in a research report on Wednesday, February 21st. Mizuho dropped their target price on Pediatrix Medical Group from $10.00 to $9.00 and set a “neutral” rating for the company in a research report on Wednesday, February 21st. Finally, TheStreet downgraded Pediatrix Medical Group from a “c” rating to a “d” rating in a report on Friday, February 23rd.

Pediatrix Medical Group Trading Down 0.2 %

Shares of MD stock opened at $9.02 on Thursday. The company has a current ratio of 1.24, a quick ratio of 1.24 and a debt-to-equity ratio of 0.73. The stock has a market capitalization of $757.95 million, a price-to-earnings ratio of -12.36, a price-to-earnings-growth ratio of 2.44 and a beta of 1.58. Pediatrix Medical Group has a 12-month low of $7.70 and a 12-month high of $15.06. The stock’s 50-day moving average price is $9.20 and its 200-day moving average price is $9.56.

Pediatrix Medical Group (NYSE:MD) last issued its quarterly earnings data on Tuesday, February 20th. The company reported $0.32 earnings per share for the quarter, topping the consensus estimate of $0.30 by $0.02. The company had revenue of $496.44 million for the quarter, compared to analysts’ expectations of $524.30 million. Pediatrix Medical Group had a positive return on equity of 10.35% and a negative net margin of 3.03%. The firm’s revenue for the quarter was down 3.4% on a year-over-year basis. During the same period in the previous year, the firm posted $0.46 earnings per share. Equities research analysts predict that Pediatrix Medical Group will post 1.12 EPS for the current fiscal year.

Institutional Trading of Pediatrix Medical Group

A number of large investors have recently modified their holdings of MD. Dimensional Fund Advisors LP increased its stake in shares of Pediatrix Medical Group by 1.4% during the fourth quarter. Dimensional Fund Advisors LP now owns 4,409,884 shares of the company’s stock valued at $41,013,000 after buying an additional 59,336 shares during the period. Pacer Advisors Inc. increased its position in Pediatrix Medical Group by 126.9% during the 4th quarter. Pacer Advisors Inc. now owns 3,235,729 shares of the company’s stock valued at $30,092,000 after purchasing an additional 1,809,828 shares during the period. Charles Schwab Investment Management Inc. raised its holdings in shares of Pediatrix Medical Group by 10.0% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,634,065 shares of the company’s stock valued at $15,197,000 after purchasing an additional 148,600 shares in the last quarter. Invenomic Capital Management LP lifted its position in shares of Pediatrix Medical Group by 93.3% in the 4th quarter. Invenomic Capital Management LP now owns 1,377,951 shares of the company’s stock worth $12,815,000 after purchasing an additional 664,955 shares during the period. Finally, Boston Partners bought a new position in shares of Pediatrix Medical Group during the fourth quarter valued at approximately $12,452,000. Hedge funds and other institutional investors own 97.71% of the company’s stock.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.